Note: Premium members can sort this table by Symbol, Date Announced, Market Cap at Announcement, Price on Announcement, Buyback/Market Cap (%), Buyback Amount and Repurchase Method.
Note: Premium members can sort this table by Symbol, Market Cap at Announcement and Buyback/Market Cap (%).
Only premium members can access all active stock buyback announcements.
| Symbol | Company | Date Announced | Market Cap at Announcement | Price on Announcement | Buyback/Market Cap (%) | Buyback Amount | Buyback Shares | Buyback Type | Repurchase Method | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 09/08/2026 | $221.47M | $11.17 | 2.26% | $5M | 447,628 | New | Market Price | |||
|
Keros Therapeutics, Inc. share repurchase details: Company Overview Keros Therapeutics, Inc. is headquartered in Lexington, Massachusetts. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. On September 08, 2026, the Board of Directors of Keros Therapeutics, Inc. (KROS) has approved a share repurchase program under which Keros Therapeutics is authorized to repurchase up to $5 million of the Company's common stock. | ||||||||||||
| UCB | United Community Banks, Inc. | 09/08/2026 | $4.23B | $35.29 | 2.37% | $100M | 2,833,664 | Additional | Market Price | |||
|
United Community Banks, Inc. share repurchase details: Company Overview United Community Banks, Inc. is headquartered in Greenville, South Carolina. The company is the financial holding company for United Community, a top-100 U.S. financial institution that offers a full range of banking, mortgage, and wealth management services across Alabama, Florida, Georgia, North Carolina, South Carolina, and Tennessee. On September 1, 2026, the Executive Committee of the Board of Directors of United Community Banks, Inc. (UCB) has approved an increase to its existing share repurchase program, authorizing an additional $100 million (through December 31, 2027) to the share repurchase program approved by the Board in 2026, of which $13 million remained outstanding under the prior authorization. | ||||||||||||
| TH | Target Hospitality Corp. | 09/08/2026 | $1.84B | $18.5 | 1.63% | $30M | 1,621,622 | New | Fixed Price | |||
|
Target Hospitality Corp. share repurchase details: Company Overview Target Hospitality Corp. is headquartered in The Woodlands, Texas. The company is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services. On September 8, 2026, Target Hospitality Corp. (TH) has entered a $30 million concurrent share repurchase agreement with underwriters in connection with a secondary offering, at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders. ($18.50) | ||||||||||||
| PTGX | Protagonist Therapeutics, Inc. | 09/08/2026 | $9.44B | $145.94 | 3.18% | $300M | 2,055,639 | New | Market Price | |||
|
Protagonist Therapeutics, Inc. share repurchase details: Company Overview Protagonist Therapeutics, Inc. is headquartered in Newark, California. The company is a biopharmaceutical company built on a proprietary peptide technology platform. On September 8, 2026, the Board of Directors of Protagonist Therapeutics, Inc. (PTGX) has authorized a share repurchase program under which Protagonist Therapeutics is authorized to repurchase up to $300 million of the Company's common stock. | ||||||||||||
| WDH | Waterdrop Inc. | 09/08/2026 | $384.45M | $1.06 | 13.01% | $50M | 46,728,972 | New | Market Price | |||
|
Waterdrop Inc. share repurchase details: Company Overview Waterdrop Inc. is headquartered in Beijing, China. The company is a leading technology platform dedicated to insurance and healthcare services with a positive social impact, operating Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, and aiming to bring insurance and healthcare services to billions through technology. On September 8, 2026, the Board of Directors of Waterdrop Inc. (WDH) has approved a new share repurchase program under which Waterdrop is authorized to repurchase up to $50 million of the Company's ordinary shares in the form of American Depositary Shares during the 12-month period through September 10, 2027. | ||||||||||||
| MSTR | Strategy Inc | 09/08/2026 | $54.24B | $136.52 | 1.84% | $1B | 7,297,672 | Additional | Market Price | |||
|
Strategy Inc share repurchase details: Company Overview Strategy Inc is headquartered in Tysons Corner, Virginia. The company operates as a Bitcoin Treasury Company, holding significant bitcoin reserves while also offering business intelligence and analytics software and services. On September 8, 2026, the Board of Directors of Strategy Inc (MSTR) has approved an increase to its existing Digital Credit Securities Repurchase Program, raising the aggregate purchase price authorized from $1 billion to $2 billion. During the period from August 31, 2026 to September 7, 2026, Strategy repurchased 1,810,885 shares of STRC for an aggregate purchase price of $176.3 million. As of September 7, 2026, $1.19 billion aggregate purchase price remained available under the Digital Credit Securities Repurchase Program. | ||||||||||||
Note: Premium members can sort this table by Symbol, Market Cap at Announcement and Buyback/Market Cap (%).
Desktop Version
| Symbol | Market Cap at Announcement | Buyback/ Market Cap (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | $221.47M | 2.26% | ||||||||||
|
Keros Therapeutics, Inc. share repurchase details: Company Overview Keros Therapeutics, Inc. is headquartered in Lexington, Massachusetts. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins. On September 08, 2026, the Board of Directors of Keros Therapeutics, Inc. (KROS) has approved a share repurchase program under which Keros Therapeutics is authorized to repurchase up to $5 million of the Company's common stock. | ||||||||||||
| UCB | $4.23B | 2.37% | ||||||||||
|
United Community Banks, Inc. share repurchase details: Company Overview United Community Banks, Inc. is headquartered in Greenville, South Carolina. The company is the financial holding company for United Community, a top-100 U.S. financial institution that offers a full range of banking, mortgage, and wealth management services across Alabama, Florida, Georgia, North Carolina, South Carolina, and Tennessee. On September 1, 2026, the Executive Committee of the Board of Directors of United Community Banks, Inc. (UCB) has approved an increase to its existing share repurchase program, authorizing an additional $100 million (through December 31, 2027) to the share repurchase program approved by the Board in 2026, of which $13 million remained outstanding under the prior authorization. | ||||||||||||
| TH | $1.84B | 1.63% | ||||||||||
|
Target Hospitality Corp. share repurchase details: Company Overview Target Hospitality Corp. is headquartered in The Woodlands, Texas. The company is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services. On September 8, 2026, Target Hospitality Corp. (TH) has entered a $30 million concurrent share repurchase agreement with underwriters in connection with a secondary offering, at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders. ($18.50) | ||||||||||||
| PTGX | $9.44B | 3.18% | ||||||||||
|
Protagonist Therapeutics, Inc. share repurchase details: Company Overview Protagonist Therapeutics, Inc. is headquartered in Newark, California. The company is a biopharmaceutical company built on a proprietary peptide technology platform. On September 8, 2026, the Board of Directors of Protagonist Therapeutics, Inc. (PTGX) has authorized a share repurchase program under which Protagonist Therapeutics is authorized to repurchase up to $300 million of the Company's common stock. | ||||||||||||
| WDH | $384.45M | 13.01% | ||||||||||
|
Waterdrop Inc. share repurchase details: Company Overview Waterdrop Inc. is headquartered in Beijing, China. The company is a leading technology platform dedicated to insurance and healthcare services with a positive social impact, operating Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, and aiming to bring insurance and healthcare services to billions through technology. On September 8, 2026, the Board of Directors of Waterdrop Inc. (WDH) has approved a new share repurchase program under which Waterdrop is authorized to repurchase up to $50 million of the Company's ordinary shares in the form of American Depositary Shares during the 12-month period through September 10, 2027. | ||||||||||||
| MSTR | $54.24B | 1.84% | ||||||||||
|
Strategy Inc share repurchase details: Company Overview Strategy Inc is headquartered in Tysons Corner, Virginia. The company operates as a Bitcoin Treasury Company, holding significant bitcoin reserves while also offering business intelligence and analytics software and services. On September 8, 2026, the Board of Directors of Strategy Inc (MSTR) has approved an increase to its existing Digital Credit Securities Repurchase Program, raising the aggregate purchase price authorized from $1 billion to $2 billion. During the period from August 31, 2026 to September 7, 2026, Strategy repurchased 1,810,885 shares of STRC for an aggregate purchase price of $176.3 million. As of September 7, 2026, $1.19 billion aggregate purchase price remained available under the Digital Credit Securities Repurchase Program. | ||||||||||||